Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Echinops cephalotes aqueous extract is a **plant-derived natural product extract** prepared from *Echinops cephalotes* and studied in **preclinical academic research** rather than as a branded or commercially developed pharmaceutical. Reported activities are pleiotropic and include **antioxidant, anti-inflammatory, antidiabetic, cardioprotective, neuroprotective, and antifungal effects** in animal and in vitro models. In the available literature, the extract has been investigated for protection against myocardial ischemia-reperfusion injury with modulation of **matrix metalloproteinase 2**, **matrix metalloproteinase 9**, and **tissue inhibitor of metalloproteinase 1** signaling, reduction of oxidative stress, improvement of glucose dysregulation and pancreatic islet changes in diabetes models, and reversal of scopolamine-induced memory impairment consistent with **acetylcholinesterase** and **butyrylcholinesterase** inhibitory activity. The agent remains a heterogeneous botanical research extract with incompletely defined active constituents, no identified commercial developer, no established brand name, and no clinical-stage development program.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on echinops cephalotes aqueous extract.